Marshall Wace’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $364M | Buy |
1,099,318
+549,396
| +100% | +$187M | 0.39% | 31 |
|
|
2025
Q4 | $219M | Buy |
549,922
+41,551
| +8% | +$18.4M | 0.21% | 77 |
|
|
2025
Q3 | $232M | Buy |
508,371
+269,798
| +113% | +$110M | 0.25% | 62 |
|
|
2025
Q2 | $77.8M | Sell |
238,573
-30,359
| -11% | -$8.4M | 0.09% | 218 |
|
|
2025
Q1 | $72.6M | Sell |
268,932
-109,717
| -29% | -$28.2M | 0.1% | 187 |
|
|
2024
Q4 | $89.1M | Buy |
378,649
+315,182
| +497% | +$82.9M | 0.11% | 174 |
|
|
2024
Q3 | $17.5M | Buy |
+63,467
| New | +$16.5M | 0.02% | 558 |
|
|
2024
Q1 | – | Sell |
-1,300
| Closed | -$249K | – | 2407 |
|
|
2023
Q4 | $249K | Buy |
+1,300
| New | +$221K | ﹤0.01% | 1925 |
|
|
2023
Q3 | – | Sell |
-11,085
| Closed | -$2.11M | – | 2159 |
|
|
2023
Q2 | $2.11M | Buy |
+11,085
| New | +$2.2M | ﹤0.01% | 1382 |
|
|
2022
Q3 | – | Sell |
-165,292
| Closed | -$24.1M | – | 3305 |
|
|
2022
Q2 | $24.1M | Buy |
+165,292
| New | +$23.4M | 0.06% | 389 |
|
|
2021
Q4 | – | Sell |
-16,427
| Closed | -$3.1M | – | 3833 |
|
|
2021
Q3 | $3.1M | Buy |
+16,427
| New | +$3.08M | 0.02% | 1237 |
|
|
2020
Q3 | – | Sell |
-58,231
| Closed | -$8.63M | – | 1547 |
|
|
2020
Q2 | $8.63M | Buy |
+58,231
| New | +$7.85M | 0.07% | 324 |
|
|
2019
Q3 | – | Sell |
-234,539
| Closed | -$17M | – | 1652 |
|
|
2019
Q2 | $17M | Buy |
+234,539
| New | +$18M | 0.14% | 161 |
|
|
2016
Q3 | – | Sell |
-34,727
| Closed | -$1.93M | – | 930 |
|
|
2016
Q2 | $1.93M | Buy |
+34,727
| New | +$2.19M | 0.02% | 597 |
|
|
2014
Q3 | – | Sell |
-5,000
| Closed | -$316K | – | 861 |
|
|
2014
Q2 | $316K | Buy |
+5,000
| New | +$297K | ﹤0.01% | 749 |
|
Other funds holding ALNY
VPM
VCM
